Soligenix Repays Loan, Boosting Financial Flexibility

TipRanksFeb 10 07:57 ET

Express News | Soligenix Inc - on Feb 5, Repays and Terminates Loan Agreement With Pontifax Medison

ReutersFeb 10 07:33 ET

Soligenix on Way to Bio Conference in NYC

Baystreet.caFeb 4 10:08 ET

Express News | Soligenix Shares Are Trading Higher After the Company Announced Interim Data From Its Investigator-initiated Study of HyBryte for Early-stage Cutaneous T-cell Lymphoma, Which Showed Over 70% of Patients Who Completed at Least 18 Weeks of Therapy...

BenzingaJan 14 07:49 ET

Express News | Hybryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

ReutersJan 14 07:30 ET

Express News | EXCLUSIVE: Soligenix Tells Benzinga 'Patients Have Responded Positively to HyBryte Therapy, With Over 70% (5 of the 6 Subjects Who Have Completed at Least 18 Weeks of Therapy) Already Achieving "Treatment Success'

BenzingaJan 14 07:15 ET